Anticoagulants

The effects of direct oral anticoagulants in nonvalvular atrial fibrillation should be assessed in actual conditions of use. France has...


Since December 2019, novel coronavirus pneumonia ( NCP ) cases have emerged in Wuhan, China, and the 2019 novel coronavirus...


The aim of study was to compare effectiveness and safety of non-vitamin K antagonist oral anticoagulants ( NOACs ) versus...


The FDA ( Food and Drug Administration ) has approved Fragmin ( Dalteparin sodium ) injection to reduce the recurrence...


Nonvitamin K antagonist oral anticoagulants ( NOACs ) are alternatives to Warfarin ( Coumadin ) in patients with nonvalvular atrial...


The results from an independent retrospective comparative study, published in the American Journal of Medicine, have shown that Dabigatran was...


Results from the phase III EINSTEIN-Jr. study has shown a strong efficacy and safety profile of Rivaroxaban ( Xarelto )...


Evidence suggests that atrial fibrillation ( AF ) is associated with a higher risk for cognitive impairment and dementia, with...


Anthracycline-induced cardiotoxicity was first reported in early 1970s. Since then, there has been increasing recognition of its association with poor...


Findings from a real-world data analysis of the U.S. Medicare database comparing the risk of stroke or systemic embolism and...


In addition to Warfarin ( Coumadin ), there are four non-vitamin K antagonist oral anticoagulants ( NOACs ) available for...


History of bleeding strongly influences decisions for anticoagulation in atrial fibrillation. Researchers have analyzed outcomes in relation to history of...


Historically, Warfarin ( Coumadin ) or Acetylsalicylic acid ( Aspirin ) have been the recommended therapeutic options for the extended...


Results from the global phase 3b ENSURE-AF ( EdoxabaN vs warfarin in subjectS UndeRgoing cardiovErsion of AtrialFibrillation ) study of...


The first non-vitamin K antagonist oral anticoagulant ( NOAC ) introduced to the market in Japan was Dabigatran ( Pradaxa...


Case reports and analyses of clinical studies and of pharmacovigilance data suggest that new oral anticoagulants ( NOACs ) are...


A study has compared efficacy and safety among novel oral anticoagulants ( NOACs ), which have not been directly compared...


The European Society of Cardiology ( ESC ) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device...


The purpose of the study was to describe the associated baseline features of atrial fibrillation patients with heart failure (...


Atrial fibrillation is often asymptomatic, but outcomes require further characterization. The study objective was to investigate the clinical presentation, management,...